Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preta da Universidade de São Paulo - (Centro de Pesquisa Clínica - S)
Welcome,         Profile    Billing    Logout  
 0 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Borges, Marcos
TT, NCT06592144: TESTO-TRIAL: Use of Testosterone in Critically Ill Patients

Active, not recruiting
4
94
RoW
Testosterone cypionate (200mg/3ml), Sesame oil (3ml)
Leticia Maria Defendi Barboza Marson
Weaning Failure, Muscle Weakness, Mechanical Ventilation Complication, ICU Acquired Weakness, Mobility Limitation
08/26
11/26
NCT03927131: Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine

Completed
3
5822
RoW
QIV-IB, TIVV-IB, TIVY-IB, QIV-IB Lot A, QIV-IB Lot B, QIV-IB Lot C
Butantan Institute, Butantan Foundation
Influenza, Human
10/23
03/24
NCT05779020: Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children .

Active, not recruiting
3
1373
RoW
Quadrivalent Influenza Vaccine (split virion, inactivated), Trivalent Influenza Vaccine (split virion, inactivated) containing Influenza B virus - Victoria lineage, Trivalent Influenza Vaccine (split virion, inactivated) containing Influenza B virus - Yamagata lineage
Butantan Institute, Fundação Butantan
Influenza, Human
09/24
08/25
ATTACC-CAP, NCT05848713: AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

Recruiting
3
4000
Canada, US, RoW
Heparin
University of Manitoba, Canadian Institutes of Health Research (CIHR), Research Manitoba, Ozmosis Research Inc., Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Critical Care Trials Group, AVANTI
Community-acquired Pneumonia
03/28
03/29
NCT05354024: Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine

Completed
2/3
4400
RoW
NDV-HXP-S 10μg, BNT162b2 30μg
Butantan Institute
Coronavirus Infections, Healthy
10/23
09/24
NCT06842173: Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults

Not yet recruiting
1/2
700
RoW
Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented, and Adjuvanted) 7.5 mcg, Avian Flu vaccine, Monovalent influenza vaccine type A (H5N8) 15 mcg, Placebo, Control arm
Butantan Institute, Fundação Butantan, Butantan Foundation
Avian Influenza A Virus
12/25
07/26
AVISA, NCT04355338: Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil

Completed
N/A
3520
RoW
Butantan Institute
COVID-19
10/21
10/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Borges, Marcos
TT, NCT06592144: TESTO-TRIAL: Use of Testosterone in Critically Ill Patients

Active, not recruiting
4
94
RoW
Testosterone cypionate (200mg/3ml), Sesame oil (3ml)
Leticia Maria Defendi Barboza Marson
Weaning Failure, Muscle Weakness, Mechanical Ventilation Complication, ICU Acquired Weakness, Mobility Limitation
08/26
11/26
NCT03927131: Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine

Completed
3
5822
RoW
QIV-IB, TIVV-IB, TIVY-IB, QIV-IB Lot A, QIV-IB Lot B, QIV-IB Lot C
Butantan Institute, Butantan Foundation
Influenza, Human
10/23
03/24
NCT05779020: Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children .

Active, not recruiting
3
1373
RoW
Quadrivalent Influenza Vaccine (split virion, inactivated), Trivalent Influenza Vaccine (split virion, inactivated) containing Influenza B virus - Victoria lineage, Trivalent Influenza Vaccine (split virion, inactivated) containing Influenza B virus - Yamagata lineage
Butantan Institute, Fundação Butantan
Influenza, Human
09/24
08/25
ATTACC-CAP, NCT05848713: AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

Recruiting
3
4000
Canada, US, RoW
Heparin
University of Manitoba, Canadian Institutes of Health Research (CIHR), Research Manitoba, Ozmosis Research Inc., Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Critical Care Trials Group, AVANTI
Community-acquired Pneumonia
03/28
03/29
NCT05354024: Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine

Completed
2/3
4400
RoW
NDV-HXP-S 10μg, BNT162b2 30μg
Butantan Institute
Coronavirus Infections, Healthy
10/23
09/24
NCT06842173: Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults

Not yet recruiting
1/2
700
RoW
Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented, and Adjuvanted) 7.5 mcg, Avian Flu vaccine, Monovalent influenza vaccine type A (H5N8) 15 mcg, Placebo, Control arm
Butantan Institute, Fundação Butantan, Butantan Foundation
Avian Influenza A Virus
12/25
07/26
AVISA, NCT04355338: Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil

Completed
N/A
3520
RoW
Butantan Institute
COVID-19
10/21
10/24

Download Options